Bristol-Myers Squibb (NYSE:BMY) Stock Position Lowered by Penn Davis Mcfarland Inc.

Penn Davis Mcfarland Inc. lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 370,659 shares of the biopharmaceutical company’s stock after selling 6,782 shares during the quarter. Bristol-Myers Squibb accounts […]

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Bristol Myers Squibb ,Christophers Boerner ,Pomalyst Imnovid ,Theodorer Samuels ,Penn Davis Mcfarland Inc ,Sevenbridge Financial Group ,Osterweis Capital Management Inc ,Bristol Myers Squibb Company Profile ,Goldman Sachs Group ,Wealth Architects ,Morgan Stanley ,Bristol Myers Squibb Company ,Securities Exchange Commission ,Penn Davis Mcfarland ,Free Report ,Myers Squibb ,Davis Mcfarland ,Bridge Financial Group ,Asset Management ,Osterweis Capital Management ,Capital Management ,Get Free Report ,Exchange Commission ,Director Theodore ,Myers Squibb Company ,Visit Holdingschannel ,Bristol Myers Squibb Daily ,Nyse Bmy ,Bmy ,Medical ,11012210 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,